| USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T-cell leukemia Q Jin, CA Martinez, KM Arcipowski, Y Zhu, BT Gutierrez-Diaz, KK Wang, ... Clinical Cancer Research 25 (1), 222-239, 2019 | 82 | 2019 |
| Subtype-specific 3D genome alteration in acute myeloid leukaemia J Xu, F Song, H Lyu, M Kobayashi, B Zhang, Z Zhao, Y Hou, X Wang, ... Nature 611 (7935), 387-398, 2022 | 74 | 2022 |
| Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c) W Fiskus, S Boettcher, N Daver, CP Mill, K Sasaki, CE Birdwell, JA Davis, ... Blood cancer journal 12 (1), 5, 2022 | 59 | 2022 |
| Posttranslational regulation of the exon skipping machinery controls aberrant splicing in leukemia Y Zhou, C Han, E Wang, AH Lorch, V Serafin, BK Cho, BT Gutierrez Diaz, ... Cancer discovery 10 (9), 1388-1409, 2020 | 39 | 2020 |
| Novel function of FAXDC2 in megakaryopoiesis Q Jin, Y Ren, M Wang, PK Suraneni, D Li, JD Crispino, J Fan, Z Huang Blood cancer journal 6 (9), e478-e478, 2016 | 32 | 2016 |
| SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia C Han, A Khodadadi-Jamayran, AH Lorch, Q Jin, V Serafin, P Zhu, ... Science Advances 8 (3), eabj8357, 2022 | 22 | 2022 |
| Novel function of PITH domain-containing 1 as an activator of internal ribosomal entry site to enhance RUNX1 expression and promote megakaryocyte differentiation B Lu, X Sun, Y Chen, Q Jin, Q Liang, S Liu, Y Li, Y Zhou, W Li, Z Huang Cellular and molecular life sciences 72, 821-832, 2015 | 17 | 2015 |
| ANP32A dysregulation contributes to abnormal megakaryopoiesis in acute megakaryoblastic leukemia X Sun, B Lu, C Han, W Qiu, Q Jin, D Li, Q Li, Q Yang, Q Wen, P Opal, ... Blood cancer journal 7 (12), 661, 2017 | 14 | 2017 |
| Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia Q Jin, B Gutierrez Diaz, T Pieters, Y Zhou, S Narang, I Fijalkwoski, C Borin, ... Science Advances 8 (49), eabq8437, 2022 | 6 | 2022 |
| Novel combination therapies against AML with 3q26 lesions and EVI1 overexpression C Birdwell, WC Fiskus, CP Mill, JA Davis, Q Jin, CD DiNardo, K Takahashi, ... Cancer Research 82 (12_Supplement), 2648-2648, 2022 | 1 | 2022 |
| Correction: A positive feedback loop regulation between NOTCH1 and USP11 in T-cell leukemia I Fijalkowski, J Wang, Q Jin, J Van Laere, V Serafin, JD Crispino, ... Leukemia 38 (1), 229-232, 2024 | | 2024 |
| A positive feedback loop regulation between NOTCH1 and USP11 in T-cell leukemia I Fijalkowski, J Wang, Q Jin, J Van Laere, V Serafin, JD Crispino, ... Leukemia 38 (1), 193-197, 2024 | | 2024 |
| Regulation of Alternative Splicing in B-Cell ALL By DYRK1A Q Jin, E Harris, JA Myers, A Cotton, J Wen, J Melo-Cardenas, A Yoshimi, ... Blood 142, 39, 2023 | | 2023 |
| Menin inhibitor-based combinations to improve efficacy and overcome resistance in AML WC Fiskus, CP Mill, C Birdwell, JA Davis, Q Jin, TM Kadia, CD DiNardo, ... Cancer Research 82 (12_Supplement), 4028-4028, 2022 | | 2022 |
| Efficacy of novel combination therapy against AML cells with mutant NPM1 CP Mill, WC Fiskus, JA Davis, CD DiNardo, C Birdwell, Q Jin, K Takahashi, ... Cancer Research 82 (12_Supplement), 4030-4030, 2022 | | 2022 |
| S109: ONCOGENIC DEUBIQUITINATION CONTROLS TYROSINE KINASE SIGNALING AND THERAPY RESPONSE IN ACUTE LYMPHOBLASTIC LEUKEMIA P Ntziachristos, Q Jin, B Gutierrez HemaSphere 6, 10-11, 2022 | | 2022 |
| 3075–ONCOGENIC DEUBIQUITINATION CONTROLS TYROSINE KINASE SIGNALING AND THERAPY RESPONSE IN ACUTE LEUKEMIA Q Jin, P Ntziachristos Experimental Hematology 100, S78, 2021 | | 2021 |
